Laura Lawrence

Laura Lawrence has over 30 years of experience in the pharmaceutical industry. Laura began their career in 1992 as a Research Scientist at Johnson & Johnson. After five years, they moved to Bristol-Myers Squibb as a Research Scientist. In 2002, they joined Rib-X Pharmaceuticals as a Clinical Study Manager and Staff Scientist I/II. In 2011, they became a Senior Director Clinical Operations and Associate/Director of Clinical Operations at Melinta Therapeutics. In 2020, they joined Cellectar Biosciences, Inc. as a Clinical Operations Leader and in 2022 they became an Executive Director at Rallybio.

Laura Lawrence attended North Carolina State University from 1988 to 1992 and obtained a Bachelor of Science in Biochemistry/Genetics. In March 2021, they obtained an Oncology University Online Graduate certification from Omnicom Health Group.